Trim GS to 65-75% of target; hard stop at $945 200 SMA weekly close
The aggressive analyst is correct on the structural macro setup (10-year crossing 5%, Polymarket hike repricing, steepener trade benefiting GS's FICC franchise, forward P/E 13.35x at low end of 10-18x range, 16.9% ROE intact, $5B quarterly buyback floor); the conservative analyst is correct on the tactical setup (50 SMA lost, MACD negative for 6 straight weeks, RSI at 39.5, Bollinger Band breakdown on elevated volume, catalyst calendar less bullish than framed). The synthesis favors a measured trim to 65-75% (upper end of trader's range) per three binding prior lessons: (1) 9/10 reflection on high-beta compounders favors 15-20% rather than 30-35% trims, (2) 9/8 reflection on mixed-signal setups favors 10-15% trims to preserve relief bounce participation, (3) 9/11 PEP lesson on unresolved range bleeding favors measured trimming with stop at multiple ATRs. The stop is tied to 200 SMA weekly close ($945), not hard $940, per lesson that tight stops below $1,000 get tagged on noise in 1.28-beta name. Full exit would overreact to technical deterioration while long-term thesis remains intact; full hold ignores binary $945 test and capitulation risk (RSI not yet sub-30).
| Position | Action |
|---|---|
| Current allocation above 75% | Trim to 65-75% of target allocation |
| Relief bounce to $1,000-$1,015 materializes within 5 trading days | Execute trim into strength, not at spot $988 |
| No relief within 5 trading days | Execute trim at market |
| Weekly close below $945 on expansion volume | Full exit of GS position |
| Price below $1,000 | Avoid fresh adds until 200 SMA is decisively resolved |
| FOMC clean delivery + $1,000 reclaim on closing basis within 5 sessions with positive MACD histogram | Add back to 100% of target allocation |
| Anthropic left-lead or co-lead confirmation | Add back to target allocation (separate trigger) |
| Q3 2026 earnings show EPS >$18 with stable comp discipline and intact backlog | Full restoration of target allocation |
GS's 14% pullback has created a textbook mean-reversion entry at 13.4× forward P/E with 92% YoY EPS growth, supported by rising 200 SMA technical structure, multiple near-term catalysts (FOMC, Anthropic IPO, Q3 earnings), and a structurally favorable macro regime for its capital markets franchise.
| Indicator | Value | Signal |
|---|---|---|
| RSI (14) | 39.53 | bearish |
| MACD Line | -5.50 | bearish |
| MACD Signal | -3.69 | bearish |
| MACD Histogram | -1.81 | bearish |
| Bollinger Upper Band | $1,059.79 | neutral |
| Bollinger Middle Band | $1,026.09 | neutral |
| Bollinger Lower Band | $992.38 | neutral |
| ATR (14) | $26.60 | neutral |
| 10 EMA | $1,020.48 | bearish |
| 50 SMA | $1,039.73 | bearish |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
When: FOMC delivers consensus 25bp hike without hawkish dot plot surprise AND GS reclaims $1,000 on closing basis within 5 sessions with positive MACD histogram divergence
Then: Add back to 100% of target
Technical indicators show momentum weakness but not yet at historically validated washout levels; Bollinger Band closes below lower band historically revert two-thirds of the time
EV: +5.3% to $1,040 within 30–60 days · concedes: Bear is correct that technical momentum is bearish in the short term (RSI 39.5, MACD negative, Bollinger Band extension); BofA's trading warning is a real market sentiment headwind even if GS fundamentals differ; The 200 SMA at $945.58 is the valid bull-bear line and a weekly close below it would be a structural breakdown
The 13.8% drawdown is not a gift but the leading edge of a cyclical earnings roll-over — the 200 SMA at $946 is the only remaining support, momentum is accelerating lower with MACD at fresh local lows, and the risk/reward is negative with an 11% downside path to $880–900 if support fails versus only ~5% upside to $1,040.
EV: -1.0% · concedes: The Anthropic IPO fee opportunity is real and GS's FICC book, prime brokerage, and AWM franchise are genuinely differentiated from BofA; The 200 SMA has not yet failed on a weekly close basis, so the regime shift has not been confirmed; A sub-30 RSI print with extreme volume would signal a washout low worth watching; A confirmed weekly close above the 10 EMA at $1,020 with positive MACD histogram would mean the trend has actually turned
→ vs conservative: Technical breakdown framing (broken 50 SMA, negative MACD, Bollinger Band close) is misreading GS historical patterns; a close below the lower Bollinger Band has been a mean-reversion buy signal for GS, not a sell signal; treating this as 2008 is wrong
→ vs conservative: 200 SMA at $945.58 is rising, not crumbling; it climbed from $833 four months ago and represents a launchpad, not a line of support about to break
→ vs conservative: Recession odds at 10% are historically low; even in a 10% recession scenario GS gets marked down only 15-20%, not destroyed, and the bear case floor of $880-900 is a three-standard-deviation event being treated as base case
→ vs conservative: Trim to 50-75% allocation reduces upside exposure while still keeping risk; if long-term thesis is intact, either hold full allocation or exit entirely; trim is the worst of both worlds
→ vs conservative: GS fundamentals at $20.98 EPS and 13.35x forward P/E represent a high-quality compounder at cyclical-trough multiple inside a structural upcycle; selling here is selling the bottom of a coil before expansion
→ vs neutral: FOMC is not a coin flip; Polymarket shows 88% September hike probability with conviction, up 35 points in one week; hawkish Fed is revenue-positive for GS FICC and debt underwriting, not stock-negative
→ vs neutral: Risk/reward is 1:4 or 1:5, not 1:2; the neutral analyst is cherry-picking a $880-900 floor as the downside scenario when it's a three-standard-deviation event
→ vs neutral: Anthropic slipping to 2027 at 86% Polymarket probability doesn't crater the stock; if it slips, GS just misses a Q4 fee pop, which is already largely in the price; one slipped catalyst doesn't invalidate the macro setup
→ vs neutral: BofA flat sales-and-trading guidance is irrelevant to GS; BofA has a shallower prime brokerage franchise, less diversified FICC book, and weaker alternatives platform; GS has the deepest FICC franchise in the peer group; penalizing GS for BofA commentary is throwing the baby out with the bathwater
| 200 SMA |
| $945.58 |
| bullish |
Support: 978.93 · 945.58 · 890 · 900 | Resistance: 992.38 · 1000 · 1026.09 · 1039.73 · 1046.19 · 1048.72 · 1059.79
The technical setup for GS is decisively bearish in the short term: price closed below the lower Bollinger Band at $992.38 for the first time in the visible window, MACD has been negative since late July with histogram now at its most negative reading since August, and RSI at 39.53 continues making lower highs and lower lows. Volume of 2,198,325 shares exceeded the 30-day average of ~1.9–2.0M, confirming the breakdown. The long-term trend remains intact as the 200 SMA continues rising (up from $833 in late May to $945.58 today), and the preferred tactical stance is to wait for either a reclaim above $1,000 with rising RSI/macd histogram tick, or a risk-managed dip-buy near the 200 SMA at ~$945 with a stop below $930. Shorting into the rising 200 SMA is deemed low-expected-value given the asymmetric bull setup, dividend support, and typical buyback authorizations for GS.
Market Cap
$287.8 B
Share Price (52w range)
$740.01 – $1,153.99
P/E (TTM)
15.27×
Forward P/E
13.35×
PEG Ratio
1.27
Price/Book
2.73×
EPS (TTM)
$64.74
Forward EPS
$74.03
Dividend Yield
1.94%
Beta
1.283
Profit Margin
31.0%
Operating Margin
42.2%
ROE
16.9%
ROA
1.07%
Book Value
$362.05
Total Assets
$2.06 T
Cash & Cash Equivalents
$179.5 B
Trading Securities
$512.7 B
Investments & Advances
$750.3 B
Net Loans
$252.8 B
Common Stockholders' Equity
$109.1 B
Total Equity
$122.8 B
Preferred Stock
$13.7 B
Treasury Stock
$125.9 B
Retained Earnings
$169.3 B
Total Debt
$434.7 B
Long-Term Debt
$326.5 B
Current Debt
$106.2 B
Net Debt
$253.1 B
Debt-to-Equity
725×
Current Ratio
1.56×
Tangible Book Value
$101.6 B
Q2 2026 Revenue
$17.23 B
Q2 2026 Net Income
$5.63 B
Q2 2026 Diluted EPS
$20.98
Q1 2026 Pretax Margin
43.5%
Effective Tax Rate
~13.2%
Revenue TTM
$67.6 B
Net Income TTM
$19.98 B
Diluted Shares
304.9 M
Q1 2026 Operating CF
-$31.87 B
Q1 2026 Financing CF
$104.29 B
Q1 2026 Dividends Paid
$1.59 B
Compensation (Q2 2026)
$5.41 B
Special Charges (T4Q)
$419 M
50-Day Moving Average
$1,044.57
200-Day Moving Average
$953.10
Strengths
Concerns
Goldman Sachs demonstrated exceptional fundamental momentum through Q2 2026, with EPS nearly doubling year-over-year to $20.98 and Q2 revenue surging 28% sequentially to $17.23B. The firm maintains a premium valuation (2.73× P/B, 13.35× forward P/E) justified by strong profitability metrics (16.9% ROE, 42.2% operating margin) and disciplined capital return through rising dividends and buybacks. Balance sheet expansion of 17% YoY to $2.06T signals active capital deployment, though elevated leverage (725× D/E) and high cyclical sensitivity require monitoring.
Macro: A hawkish pivot is now priced in. Polymarket-implied probabilities (all at $1M+ volume): Fed Rate Hike by September 2026 FOMC at 88% (+35.5 pp week-over-week); Fed Rate Hike by October FOMC at 88% (+27.0 pp); Exactly 1 hike in 2026 at 50% (+6.0 pp); NO Fed rate hikes in 2026 at 6% (−23.0 pp); NO Fed rate cuts in 2026 at 94% (+1.2 pp); U.S. recession by end of 2026 at 10% (+3.0 pp). The 10-year U.S. Treasury yield crossed 5% for the first time in years, briefly touching a multi-year high before paring. FRED macro series (CPI, core PCE, fed funds, unemployment) returned DATA_UNAVAILABLE; rates commentary relies on Polymarket-implied probabilities and journalism from WSJ, Reuters, Barrons, and MT Newswires.